# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-250660
Filing Date
2024-11-04
Accepted
2024-11-04 16:33:55
Documents
41
Period of Report
2024-11-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | d871673d6k.htm | 6-K | 9966
2 | EX-99.1 | d871673dex991.htm | EX-99.1 | 15139
3 | EX-99.2 | d871673dex992.htm | EX-99.2 | 43423
4 | GRAPHIC | g871673ex99_2p10g1.jpg | GRAPHIC | 85603
5 | GRAPHIC | g871673ex99_2p11g1.jpg | GRAPHIC | 313390
6 | GRAPHIC | g871673ex99_2p12g1.jpg | GRAPHIC | 275849
7 | GRAPHIC | g871673ex99_2p13g1.jpg | GRAPHIC | 383410
8 | GRAPHIC | g871673ex99_2p14g1.jpg | GRAPHIC | 81914
9 | GRAPHIC | g871673ex99_2p15g1.jpg | GRAPHIC | 180467
10 | GRAPHIC | g871673ex99_2p16g1.jpg | GRAPHIC | 236473
11 | GRAPHIC | g871673ex99_2p17g1.jpg | GRAPHIC | 240383
12 | GRAPHIC | g871673ex99_2p18g1.jpg | GRAPHIC | 340727
13 | GRAPHIC | g871673ex99_2p19g1.jpg | GRAPHIC | 63049
14 | GRAPHIC | g871673ex99_2p1g1.jpg | GRAPHIC | 167761
15 | GRAPHIC | g871673ex99_2p20g1.jpg | GRAPHIC | 228018
16 | GRAPHIC | g871673ex99_2p21g1.jpg | GRAPHIC | 344071
17 | GRAPHIC | g871673ex99_2p22g1.jpg | GRAPHIC | 343839
18 | GRAPHIC | g871673ex99_2p23g1.jpg | GRAPHIC | 57799
19 | GRAPHIC | g871673ex99_2p24g1.jpg | GRAPHIC | 307788
20 | GRAPHIC | g871673ex99_2p25g1.jpg | GRAPHIC | 418626
21 | GRAPHIC | g871673ex99_2p26g1.jpg | GRAPHIC | 58551
22 | GRAPHIC | g871673ex99_2p27g1.jpg | GRAPHIC | 409935
23 | GRAPHIC | g871673ex99_2p28g1.jpg | GRAPHIC | 243741
24 | GRAPHIC | g871673ex99_2p29g1.jpg | GRAPHIC | 50331
25 | GRAPHIC | g871673ex99_2p2g1.jpg | GRAPHIC | 588219
26 | GRAPHIC | g871673ex99_2p30g1.jpg | GRAPHIC | 299268
27 | GRAPHIC | g871673ex99_2p31g1.jpg | GRAPHIC | 282383
28 | GRAPHIC | g871673ex99_2p32g1.jpg | GRAPHIC | 373938
29 | GRAPHIC | g871673ex99_2p33g1.jpg | GRAPHIC | 291977
30 | GRAPHIC | g871673ex99_2p34g1.jpg | GRAPHIC | 62752
31 | GRAPHIC | g871673ex99_2p35g1.jpg | GRAPHIC | 365689
32 | GRAPHIC | g871673ex99_2p36g1.jpg | GRAPHIC | 311317
33 | GRAPHIC | g871673ex99_2p37g1.jpg | GRAPHIC | 80431
34 | GRAPHIC | g871673ex99_2p3g1.jpg | GRAPHIC | 347193
35 | GRAPHIC | g871673ex99_2p4g1.jpg | GRAPHIC | 361158
36 | GRAPHIC | g871673ex99_2p5g1.jpg | GRAPHIC | 254569
37 | GRAPHIC | g871673ex99_2p6g1.jpg | GRAPHIC | 290371
38 | GRAPHIC | g871673ex99_2p7g1.jpg | GRAPHIC | 78760
39 | GRAPHIC | g871673ex99_2p8g1.jpg | GRAPHIC | 232362
40 | GRAPHIC | g871673ex99_2p9g1.jpg | GRAPHIC | 348030
41 | GRAPHIC | g871673g1104201849716.jpg | GRAPHIC | 2573
| Complete submission text file | 0001193125-24-250660.txt |  | 13024196

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 241424118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)